Quintela Fandiño, Miguel Angel miguel.quintela@uam.es
Actividades
- Artículos 52
- Libros 0
- Capítulos de libro 0
- Congresos 1
- Documentos de trabajo 0
- Informes técnicos 1
- Proyectos de investigación 0
- Tesis dirigidas 1
- Patentes o licencias de software 0
p27(Kip1) V109G as a biomarker for CDK4/6 inhibitors indication in hormone receptor-positive breast cancer
- Mouron, S
- Bueno, MJ
- Munoz, M
- Torres, R
- Rodriguez, S
- Apala, JV
- Silva, J
- Sanchez-Bayona, R
- Manso, L
- Guerra, J
- Rodriguez-Lajusticia, L
- Malon, D
- Malumbres, M
- Quintela-Fandino, M
Jnci Cancer Spectrum - 1/4/2023
- ISSN 25155091
- iMarina
When should we order a next generation sequencing test in a patient with cancer?
- Colomer R, Mondejar R, Romero-Laorden N, Alfranca A, Sanchez-Madrid F, Quintela-Fandino M
Eclinicalmedicine (p. 100487-100487) - 1/8/2020
10.1016/j.eclinm.2020.100487 Ver en origen
- ISSN 25895370
- iMarina
- iMarina
Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
- Hitt, R
- Amador, ML
- Quintela-Fandino, M
- Jimeno, A
- del Val, O
- Hernando, S
- Cortes-Funes, H;
Cancer (p. 106-111) - 1/1/2006
10.1002/cncr.21579 Ver en origen
- ISSN 0008543X
Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement
- Colomer R
- Miranda J
- Romero-Laorden N
- Hornedo J
- González-Cortijo L
- Mouron S
- Bueno MJ
- Mondéjar R
- Quintela-Fandino M
Eclinicalmedicine - 1/6/2023
10.1016/j.eclinm.2023.102029 Ver en origen
- ISSN 25895370
Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancer
- Jimeno, R.
- Mouron, S.
- Salgado, R.
- Loi, S.
- Pérez-Mies, B.
- Sánchez-Bayona, R.
- Manso, L.
- Martínez, M.
- Garrido-García, A.
- Serrano-Pardo, R.
- Colomer, R.
- Quintela-Fandino, M.
Clinical & Translational Oncology (p. 1124-1131) - 1/4/2023
Editor: Springer Science and Business Media Deutschland GmbH
10.1007/s12094-022-03006-3 Ver en origen
- ISSN 1699048X
- ISSN/ISBN 1699-3055
- Dialnet
- iMarina
Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer
- Alvarez-Fernandez, Monica
- Sanz-Flores, Maria
- Sanz-Castillo, Belen
- Salazar-Roa, Maria
- Partida, David
- Zapatero-Solana, Elisabet
- Ali, H. Raza
- Manchado, Eusebio
- Lowe, Scott
- VanArsdale, Todd
- Shields, David
- Caldas, Carlos
- Quintela-Fandino, Miguel
- Malumbres, Marcos;
Cell Death And Differentiation (p. 828-840) - 1/5/2018
10.1038/s41418-017-0024-0 Ver en origen
- ISSN 13509047
The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk
- Arpaia, E.
- Blaser, H.
- Quintela-Fandino, M.
- Duncan, G.
- Leong, H. S.
- Ablack, A.
- Nambiar, S. C.
- Lind, E. F.
- Silvester, J.
- Fleming, C. K.
- Rufini, A.
- Tusche, M. W.
- Bruestle, A.
- Ohashi, P. S.
- Lewis, J. D.
- Mak, T. W.;
Oncogene (p. 884-896) - 16/2/2012
10.1038/onc.2011.288 Ver en origen
- ISSN 09509232
Targeting the Tumor Stroma in Breast Cancer
- Sanchez-Ruiz J
- Quintela-Fandino M
Current Breast Cancer Reports (p. 71-79) - 28/3/2015
10.1007/s12609-014-0173-9 Ver en origen
- ISSN 19434596
Targeting cytoskeleton reorganisation as antimetastatic treatment
- Quintela-Fandino, Miguel
- Gonzalez-Martin, Antonio
- Colomer, Ramon
Clinical & Translational Oncology (p. 662-669) - 1/10/2010
10.1007/s12094-010-0575-8 Ver en origen
- ISSN 1699048X
Targeting Tumor Mitochondrial Metabolism Overcomes Resistance to Antiangiogenics
- Navarro, P
- Bueno, MJ
- Zagorac, I
- Mondejar, T
- Sanchez, J
- Mouron, S
- Munoz, J
- Gomez-Lopez, G
- Jimenez-Renard, V
- Mulero, F
- Chandel, NS
- Quintela-Fandino, M
Cell Reports (p. 2705-2718) - 21/6/2016
10.1016/j.celrep.2016.05.052 Ver en origen
- ISSN 22111247
Este/a investigador/a no tiene libros.
Este/a investigador/a no tiene capítulos de libro.
Phase I clinical trial of neoadjuvant BIBF1120 plus weekly paclitaxel (P) in early HER-2 negative breast cancer. CNIO-BR-01-2010 GEICAM 2010-10 study
- Quintela-Fandino, M.
- Urruticoechea, A.
- Guerra, J.
- Gil, M.
- Gonzalez-Martin, A.
- Marquez, R.
- Hernandez-Agudo, E.
- Rodriguez-Martin, C.
- Gil, M.
- Bratos, R.
- Escudero, M. J.
- Colomer, R.;
Cancer Research - 15/12/2013
10.1158/0008-5472.sabcs13-pd5-8 Ver en origen
- ISSN 00085472
Este/a investigador/a no tiene documentos de trabajo.
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3K?/?, in Patients with Advanced Solid Tumors
- Choudhury AD, Higano CS, de Bono JS, Cook N, Rathkopf DE, Wisinski KB, Martin-Liberal J, Linch M, Heath EI, Baird RD, García-Carbacho J, Quintela-Fandino M, Barry ST, de Bruin EC, Colebrook S, Hawkins G, Klinowska T, Maroj B, Moorthy G, Mortimer PG, Moschetta M, Nikolaou M, Sainsbury L, Shapiro GI, Siu LL, Hansen AR
Clinical Cancer Research (p. 2257-2269) - 1/1/2022
10.1158/1078-0432.ccr-21-3087 Ver en origen
- ISSN 15573265
Este/a investigador/a no tiene proyectos de investigación.
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Scopus Author ID
-
Dialnet id